Free Trial
NASDAQ:MDBH

MDB Capital Q1 2024 Earnings Report

MDB Capital logo
$3.44 +0.04 (+1.18%)
Closing price 10/8/2025 03:49 PM Eastern
Extended Trading
$3.14 -0.30 (-8.58%)
As of 10/8/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDB Capital EPS Results

Actual EPS
-$0.78
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MDB Capital Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

MDB Capital Announcement Details

Quarter
Q1 2024
Time
N/A
Conference Call Date
Monday, May 13, 2024
Conference Call Time
7:00AM ET

Earnings Documents

MDB Capital Earnings Headlines

Robinhood warning
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
MDB Capital Holdings Provides Second Quarter 2025 Update
See More MDB Capital Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MDB Capital? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MDB Capital and other key companies, straight to your email.

About MDB Capital

MDB Capital (NASDAQ:MDBH), through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.

View MDB Capital Profile

More Earnings Resources from MarketBeat